Skip to content
OASYS NOW logo — Health Data Intelligence for Healthcare & Life Sciences | Pr...

OASYS NOW

Health Data Intelligence for Healthcare & Life Sciences | Privacy-by-Design | No harmonisation required

Founded 2021 The Netherlands The Netherlands 11 employees Total: $1.25M AI, Biopharma +4

General Information

Company Name OASYS NOW
Founded Year 2021
Location The Netherlands The Netherlands
Employees 11
Industries AI, Biopharma, Biotechnology +3
Business Model B2B, SaaS, D2C
Revenue Model Subscription, Usage Based, Service Fee

BounceWatch is an independent company data service, not affiliated with OASYS NOW. To contact OASYS NOW, visit oasysnow.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does OASYS NOW compare?

A PDF of OASYS NOW and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting OASYS NOW soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About OASYS NOW

OASYS NOW, a Dutch startup founded in 2021, is pioneering the realm of Health Data Intelligence by offering innovative solutions that allow health data holders to capitalize on their existing clinical data infrastructure. Emphasizing a Privacy-by-Design philosophy, the company ensures that sensitive information is processed without any data harmonization or offsite data transfer, effectively addressing a critical pain point in the healthcare and life sciences industries.

Their portfolio includes De-ID, an on-premise pseudonymization tool that meets EHDS compliance standards; AI Readiness, a foundation for scalable AI applications; and ELaiGIBLE, a solution for accelerating patient recruitment in clinical trials. Garnering recognition from notable lists like Forbes 30 Under 30 (Europe) and SLUSH 100, OASYS NOW stands out in the competitive sectors of AI, Biotechnology, and Cyber Security.

Recently, the company secured a €1.00M Early VC investment from investors such as Cherry Ventures and General Catalyst, signaling strong market confidence and growth potential.

Business keywords: Health Data Intelligence, Privacy-by-Design, Pseudonymisation, AI Readiness, EHR Data Management, AI-powered Patient Recruitment, Clinical Trials, Data Privacy, Privacy Enhancing Technologies, Federated Learning, De-Identification, Trustworthy AI, Confidential AI, Sovereign AI

Services & Products

Clinical Data Analysis
AI-Powered Patient Pre-Screening
Health Data Pseudonymization
Interoperability Solutions
Multi-Site Data Collaboration

Target Customers

Hospitals Research Centers Clinical Trial Sites Data Governance Teams Compliance Experts

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC €1.00M 2
Cherry Ventures, General Catalyst
01 Nov 2024
Convertible Note Undisclosed 1
ASIF Ventures
01 Dec 2023
Convertible Note €250.00K 3
Golden Egg Check, TenNine VC. +1
01 May 2023
Support Program Undisclosed 1
YES!Delft
01 Dec 2021
Spinout Undisclosed 1
Erasmus University Rotterdam
01 Mar 2021

OASYS NOW Alternatives & Competitors

View All Alternatives
OASYS NOW vs
Sano Genetics
Sano Genetics United Kingdom

Accelerating the world's transition to precision medicine.

50 employees
Biopharma, Biotechnology
OASYS NOW vs
Inpher
Inpher United States

Privacy-enhancing computation that empowers organizations to harness the potential of AI securely an...

Venture round
12 employees
AI, Analytics
OASYS NOW vs
Ancora.ai
Ancora.ai Switzerland

Ancora.ai is a patient-first, digital clinical trial navigation tool connecting cancer patients to c...

Grant
9 employees
AI, Big Data

FAQ About OASYS NOW

Health Data Intelligence for Healthcare & Life Sciences | Privacy-by-Design | No harmonisation required
OASYS NOW was founded in 2021.
OASYS NOW is headquartered in The Netherlands.
OASYS NOW operates in AI, Biopharma, Biotechnology, Cyber Security, Life Sciences and Pharmaceutical. Its work centres on Health Data Intelligence, Privacy-by-Design, Pseudonymisation and AI Readiness. Its customers include Hospitals, Research Centers and Clinical Trial Sites.
OASYS NOW has a B2B, SaaS and D2C business model. Its revenue comes from Subscription, Usage Based and Service Fee.
OASYS NOW has approximately 11 employees.
OASYS NOW has completed 5 funding rounds, raising a total of $1.25M.
OASYS NOW offers: Clinical Data Analysis, AI-Powered Patient Pre-Screening, Health Data Pseudonymization, Interoperability Solutions, Multi-Site Data Collaboration.
Top alternatives and competitors to OASYS NOW include Sano Genetics, Inpher, Ancora.ai, radiomics.bio, OWKIN. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
OASYS NOW and Sano Genetics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for OASYS NOW, https://bouncewatch.com/company/oasys-now, updated 6 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout